Evidence map›Paper›PMID 25851125›Full record

ArticleStem cells (Dayton, Ohio)2015

Notch Receptor-Ligand Engagement Maintains Hematopoietic Stem Cell Quiescence and Niche Retention.

Weihuan Wang, Shuiliang Yu, Grant Zimmerman, Yiwei Wang, Jay Myers, Vionnie W C Yu, Dan Huang, Xiaoran Huang, Jeongsup Shim, Yuanshuai Huang and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  9. Ex Vivo Expansion and Homing of Human Cord Blood Hematopoietic Stem Cells.Advances in experimental medicine and biology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Role ofFrontiers in cell and developmental biology · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Weihuan WangDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Shuiliang YuDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Grant ZimmermanDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Yiwei WangDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Jay MyersDepartment of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USA.
Vionnie W C YuCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Dan HuangDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Xiaoran HuangDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Jeongsup ShimDepartment of Pathology, Genentech, Inc., South San Francisco, California, USA.
Yuanshuai HuangDepartment of Blood Transfusion, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan Province, People's Republic of China.
William XinUniversity School, Hunting Valley, Ohio, USA.
Peter QiaoDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Minhong YanDepartment of Molecular Biology Oncology, Genentech, Inc., South San Francisco, California, USA.
Wei XinDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
David T ScaddenCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pamela StanleyDepartment of Cell Biology, Albert Einstein College of Medicine, New York, New York, USA.
John B LoweDepartment of Pathology, Genentech, Inc., South San Francisco, California, USA.
Alex Y HuangDepartment of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USA.
Christian W SiebelDepartment of Molecular Biology Oncology, Genentech, Inc., South San Francisco, California, USA.
Lan ZhouDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Case Western Reserve University · USUniversity School · USAlbert Einstein College of Medicine · USFirst Affiliated Hospital of Sichuan Medical University · CNHarvard Stem Cell Institute · USMassachusetts General Hospital · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Microenvironmental control of progenitors in organ dysfunction and repairU01HL100402 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KIM, CARLA F., SCADDEN, DAVID T · 2009 to 2015
$8.5M
MECHANISMS OF HEMATOPOIESIS IN AIDSR01HL044851 · NHLBI · NEW ENGLAND DEACONESS HOSPITAL · PI SCADDEN, DAVID T · 1991 to 2015
$7.7M
Glycosylation Mutants of Mice and Animal CellsR01CA030645 · NCI · YESHIVA UNIVERSITY · PI STANLEY, PAMELA M · 1985 to 2010
$5.2M
Targeting Notch2 in Hematopoietic Cell Therapy.R01HL103827 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI ZHOU, LAN · 2012 to 2022
$4.3M
Roles of Glycoslyation in Notch SignalingR01CA095022 · NCI · YESHIVA UNIVERSITY · PI STANLEY, PAMELA M · 2002 to 2011
$4.1M
Roles of Glycoslyation in Notch SignalingR01GM106417 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STANLEY, PAMELA M · 2013 to 2021
$3.8M
Building the Hematopoietic Stem Cell NicheR01EB014703 · NIBIB · HARVARD UNIVERSITY · PI MOONEY, DAVID J, SCADDEN, DAVID T · 2011 to 2014
$3.1M
Stem Cell Engagement of the NicheR01HL097794 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SCADDEN, DAVID T · 2009 to 2012
$2.4M
Regulation of Granulopoiesis by Fucosylation-Dependent Notch SignalingK08HL089218 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI ZHOU, LAN · 2008 to 2012
$637k
Mesenchyme Organizers of Organ Development, Maintenance and RepairR03HL096372 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SCADDEN, DAVID T · 2009 to 2009
$44k
PROTON THERAPY RESEARCH AND TREATMENT CENTERC06CA059267 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI GOITEIN, MICHAEL · 1992 to 1995
–
NCI NIH HHS C06 CA059267NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA030645NCI NIH HHS R01 CA095022NHLBI NIH HHS HL044851NHLBI NIH HHS HL097794NHLBI NIH HHS HL100402NHLBI NIH HHS HL103827NHLBI NIH HHS HL96372NHLBI NIH HHS K08 HL089218NHLBI NIH HHS R01 HL044851NHLBI NIH HHS R01 HL097794NHLBI NIH HHS R01 HL103827NHLBI NIH HHS R03 HL096372NHLBI NIH HHS U01 HL100402NIBIB NIH HHS EB14703NIBIB NIH HHS R01 EB014703NIGMS NIH HHS R01 GM106417NIGMS NIH HHS R01GM106417
6 · The paper itself

Abstract

Notch is long recognized as a signaling molecule important for stem cell self-renewal and fate determination. Here, we reveal a novel adhesive role of Notch-ligand engagement in hematopoietic stem and progenitor cells (HSPCs). Using mice with conditional loss of O-fucosylglycans on Notch EGF-like repeats important for the binding of Notch ligands, we report that HSPCs with faulty ligand binding ability display enhanced cycling accompanied by increased egress from the marrow, a phenotype mainly attributed to their reduced adhesion to Notch ligand-expressing stromal cells and osteoblastic cells and their altered occupation in osteoblastic niches. Adhesion to Notch ligand-bearing osteoblastic or stromal cells inhibits wild type but not O-fucosylglycan-deficient HSPC cycling, independent of RBP-JK -mediated canonical Notch signaling. Furthermore, Notch-ligand neutralizing antibodies induce RBP-JK -independent HSPC egress and enhanced HSPC mobilization. We, therefore, conclude that Notch receptor-ligand engagement controls HSPC quiescence and retention in the marrow niche that is dependent on O-fucosylglycans on Notch.

Indexed as

AnimalsHematopoietic Stem CellsHumansMiceReceptors, NotchSignal TransductionStem Cell NicheStromal CellsReceptors, NotchHSC egress and mobilizationHSC quiescence and niche retentionNotch receptor-ligand interactionsO-fucosylglycans on Notch

Identifiers

PMID25851125
PMCPMC4478168
OpenAlexW1544115089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.